Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/03/18
End: 11/28/18
Due: 11/28/19
Phase: N/A
Priority: Normal
Start: 01/19/15
End: 08/10/15
Due: 08/10/16
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Evaluation of Infectivity and Illness of Norwalk GI.1 Virus Lot 001-09NV in the Human Challenge Model | NCT03721549 | WCCT Global | user2@example.com | None | 2018-10-03 | 2018-11-28 | 2019-11-28 | - | - | 2025-07-14 |
| Single Ascending Dose Challenge Study to Determine Safety and Reactogenicity of an Influenza Challenge Virus | NCT04106817 | WCCT Global | user2@example.com | None | 2015-01-19 | 2015-08-10 | 2016-08-10 | - | - | 2025-07-14 |